Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Neoadjuvant Endocrine Therapy
Interventions: DRUG: Tamoxifen 20mg|DRUG: Anastrozole 1mg|DRUG: Letrozole 2.5mg|DRUG: Goserelin|DRUG: Triptorelin
Sponsor: Blokhin's Russian Cancer Research Center